Ordinary investors are free to avoid the short-termism that plagues professionals

Recent indications show profitability is coming under pressure

Leading oil and gas companies have a lot to fear from eventual introduction of a carbon tax

Practice has yielded handsome returns in the past but failed to bear fruit in recent years

Opinion: Fears about GMO are not borne out by the science; a rethink is in order

Whatever about the short term, emerging markets can be a very good option

Notion that past gains were inevitable and future is murky is bedevilled by hindsight bias

Merrill Lynch monthly fund manager survey suggests indices haven’t yet bottomed

Conference to hear how anti-GMO groups have hijacked ‘green’ and ‘sustainable’

Department of Agriculture said it was guided by European Food Safety Authority on use of Roundup

Ethical investors can outperform if they engage with corporate sinners

Green criticism has undermined public and political confidence in GMOs but science proves they are no riskier than more traditional methods

Denis Naughten recommends opting out of directive on GMOs

Bears see this as temporary but bulls think profit margins have risen to a permanently higher plateau

Stocktake: with value stocks in a slump, the tortoise and hare approach may lose its appeal

Stocktake: Bitcoin ‘virus’ peaks; Barclays’ equity study; Buffet the billionaire boy

Is it really that difficult to go against the herd? In a nutshell, yes

Performance does not persist, as shown by the latest scorecard from S&P Dow Jones Indices

Why is herding such a problem in financial markets?

Stocktake: despite strong market rebound, stocks likely to retest recent lows